Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sienna Biopharmaceuticals, Inc. (SNNA) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sienna Biopharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1656328.
Total stock buying since 2017: $84,682,197.
Total stock sales since 2017: $1,683,256.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 33,487,000 | $83,717,500 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 85,504 | $1,683,256 | 0 | $0 |
| 2017 | 63,650 | $964,697 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-02 | 33,487,000 | $83,717,500 | 0 | $0 | 0 | $0 |
| 2018-04 | 0 | $0 | 31,075 | $622,972 | 0 | $0 |
| 2018-03 | 0 | $0 | 54,429 | $1,060,284 | 0 | $0 |
| 2017-09 | 1,250 | $28,697 | 0 | $0 | 0 | $0 |
| 2017-08 | 62,400 | $936,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-22 | Burow Kristina (Director) | Buy | 6,497,400 | 2.50 | 16,243,500 |
| 2019-02-22 | Leonard Keith R | Buy | 300,000 | 2.50 | 750,000 |
| 2019-02-22 | Gillis Steven (10% Owner) | Buy | 6,497,400 | 2.50 | 16,243,500 |
| 2019-02-22 | Nelsen Robert (10% Owner) | Buy | 6,497,400 | 2.50 | 16,243,500 |
| 2019-02-22 | More Robert J | Buy | 300,000 | 2.50 | 750,000 |
| 2018-04-30 | Harris Todd (Head of Corporate Development) | Sale | 100 | 20.00 | 2,000 |
| 2018-04-25 | Harris Todd (Head of Corporate Development) | Sale | 300 | 20.00 | 6,000 |
| 2018-04-24 | Harris Todd (Head of Corporate Development) | Sale | 150 | 20.00 | 3,000 |
| 2018-04-23 | Harris Todd (Head of Corporate Development) | Sale | 525 | 20.00 | 10,500 |
| 2018-04-18 | Harris Todd (Head of Corporate Development) | Sale | 15,810 | 20.09 | 317,607 |
| 2018-04-17 | Harris Todd (Head of Corporate Development) | Sale | 2,201 | 20.00 | 44,020 |
| 2018-04-10 | Harris Todd (Head of Corporate Development) | Sale | 3,779 | 20.02 | 75,640 |
| 2018-04-09 | Harris Todd (Head of Corporate Development) | Sale | 2,824 | 20.00 | 56,480 |
| 2018-04-05 | Harris Todd (Head of Corporate Development) | Sale | 5,386 | 20.00 | 107,725 |
| 2018-03-29 | More Robert J | Sale | 14,429 | 18.78 | 270,976 |
| 2018-03-28 | More Robert J | Sale | 10,000 | 18.84 | 188,400 |
| 2018-03-19 | Harris Todd (Head of Corporate Development) | Sale | 5,876 | 20.00 | 117,520 |
| 2018-03-12 | Harris Todd (Head of Corporate Development) | Sale | 3,452 | 20.11 | 69,430 |
| 2018-03-09 | Harris Todd (Head of Corporate Development) | Sale | 2,438 | 20.01 | 48,784 |
| 2018-03-08 | Harris Todd (Head of Corporate Development) | Sale | 14,530 | 20.03 | 291,094 |
| 2018-03-07 | Harris Todd (Head of Corporate Development) | Sale | 3,704 | 20.00 | 74,080 |
| 2017-09-18 | Fenton Dennis M | Buy | 1,250 | 22.96 | 28,697 |
| 2017-08-01 | Andrews Timothy K. (General Counsel & Secretary) | Buy | 15,000 | 15.00 | 225,000 |
| 2017-08-01 | Lizzul Paul F. (Chief Medical Officer) | Buy | 10,000 | 15.00 | 150,000 |
| 2017-08-01 | Stroehmann Diane (See Remarks) | Buy | 7,000 | 15.00 | 105,000 |
| 2017-08-01 | Peterson Richard D (Chief Financial Officer) | Buy | 7,000 | 15.00 | 105,000 |
| 2017-08-01 | Leonard Keith R | Buy | 16,700 | 15.00 | 250,500 |
| 2017-08-01 | Mast Erle T | Buy | 6,700 | 15.00 | 100,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of SNNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sienna Biopharmaceuticals, Inc. (symbol SNNA, CIK number 1656328) see the Securities and Exchange Commission (SEC) website.